Structures by: Robeyns K.
Total: 236
(1,2,2-triiodovinyl)benzene
C8H5I3
CrystEngComm (2016) 18, 5 683
a=10.5124(3)Å b=10.5580(3)Å c=20.3568(7)Å
α=90° β=97.390(3)° γ=90°
CaCl2 etiracetam Isonicotinamide
C22H36CaN6O6,2(Cl)
Chemical communications (Cambridge, England) (2020) 56, 86 13229-13232
a=7.968(2)Å b=12.170(4)Å c=15.304(4)Å
α=87.17(2)° β=86.30(2)° γ=74.76(2)°
RS-naproxen L-proline 1:2 cocrystal
C14H14O3,2(C5H9NO2)
CrystEngComm (2018) 20, 45 7308
a=5.84172(9)Å b=8.98394(13)Å c=45.6816(8)Å
α=90° β=90° γ=90°
2-[(E)-2-(2-hydroxy-3-methoxyphenyl)ethenyl]-1,3,3-trimethyl-3H-indol-1-ium dihydrate bromide
C20H22NO21,Br1,2(H2O)
CrystEngComm (2018) 20, 24 3318
a=11.5976(3)Å b=23.9015(6)Å c=7.36093(15)Å
α=90° β=98.766(2)° γ=90°
C19H18Cl3N2O3Zn,C19H19N2O3
C19H18Cl3N2O3Zn,C19H19N2O3
CrystEngComm (2019) 21, 33 4925
a=11.8909(7)Å b=12.6582(7)Å c=25.0471(16)Å
α=90° β=98.073(6)° γ=90°
C19H20Cl2N2O4Zn,2(H2O)
C19H20Cl2N2O4Zn,2(H2O)
CrystEngComm (2019) 21, 33 4925
a=12.388(6)Å b=13.671(7)Å c=14.855(8)Å
α=108.02(5)° β=101.20(4)° γ=101.01(4)°
C38H36Br2N4O6Zn
C38H36Br2N4O6Zn
CrystEngComm (2019) 21, 33 4925
a=9.1737(6)Å b=14.9690(14)Å c=15.421(2)Å
α=116.717(11)° β=98.405(8)° γ=89.487(7)°
C27H42N4O4P2S4,0.5(C6H14)
C27H42N4O4P2S4,0.5(C6H14)
CrystEngComm (2012) 14, 4 1324
a=8.511Å b=23.619(9)Å c=19.907(9)Å
α=90.00° β=109.35(4)° γ=90.00°
C12H9HgN7O,C2H6O
C12H9HgN7O,C2H6O
CrystEngComm (2017)
a=8.2360(2)Å b=14.4820(3)Å c=14.0530(2)Å
α=90.00° β=97.015(2)° γ=90.00°
C12H10N4O
C12H10N4O
CrystEngComm (2017)
a=7.6439(7)Å b=11.271(2)Å c=13.576(3)Å
α=67.807(18)° β=79.669(11)° γ=81.247(11)°
C14H17HgN7O3
C14H17HgN7O3
CrystEngComm (2017)
a=14.4728(11)Å b=14.4895(12)Å c=16.2609(12)Å
α=90.00° β=90.00° γ=90.00°
C14H14HgN7O1.5
C14H14HgN7O1.5
CrystEngComm (2017)
a=8.1973(2)Å b=14.0633(3)Å c=14.2839(3)Å
α=90° β=96.485(2)° γ=90°
C15H17HgN7O2
C15H17HgN7O2
CrystEngComm (2017)
a=10.3282(15)Å b=14.3823(17)Å c=11.7472(16)Å
α=90° β=99.721(7)° γ=90°
C26H22N2O4
C26H22N2O4
CrystEngComm (2016) 18, 38 7249
a=14.0292(9)Å b=5.0669(4)Å c=14.7229(11)Å
α=90° β=99.433(7)° γ=90°
C26H22N2O4
C26H22N2O4
CrystEngComm (2016) 18, 38 7249
a=6.7362(6)Å b=24.2039(15)Å c=6.8686(5)Å
α=90.00° β=112.293(9)° γ=90.00°
C9H7N5O3
C9H7N5O3
CrystEngComm (2016) 18, 38 7284
a=5.3288(4)Å b=18.3034(13)Å c=10.3561(8)Å
α=90° β=94.819(7)° γ=90°
C10H10N4O2
C10H10N4O2
CrystEngComm (2016) 18, 38 7284
a=19.9241(13)Å b=19.9241(13)Å c=5.1153(5)Å
α=90° β=90° γ=90°
C9H8N4O2
C9H8N4O2
CrystEngComm (2016) 18, 38 7284
a=5.8474(12)Å b=21.040(4)Å c=7.5567(18)Å
α=90° β=107.25(2)° γ=90°
C9H7ClN4O
C9H7ClN4O
CrystEngComm (2016) 18, 38 7284
a=3.7737(14)Å b=14.259(5)Å c=8.993(3)Å
α=90° β=101.23(4)° γ=90°
C9H7BrN4O
C9H7BrN4O
CrystEngComm (2016) 18, 38 7284
a=13.4933(16)Å b=10.4263(13)Å c=7.2548(13)Å
α=90° β=93.731(13)° γ=90°
C9H8N4O2
C9H8N4O2
CrystEngComm (2016) 18, 38 7284
a=11.7895(5)Å b=11.7895(5)Å c=17.6053(8)Å
α=90° β=90° γ=120°
C13H10N4O
C13H10N4O
CrystEngComm (2016) 18, 38 7284
a=8.7625(6)Å b=5.8854(4)Å c=11.0081(12)Å
α=90° β=91.833(7)° γ=90°
C12H9BrN2O
C12H9BrN2O
RSC Adv. (2016) 6, 59 53669
a=4.5103(3)Å b=19.8005(15)Å c=12.1942(8)Å
α=90.00° β=95.592(7)° γ=90.00°
C12H9BrN2O
C12H9BrN2O
RSC Adv. (2016) 6, 59 53669
a=6.1946(6)Å b=7.0152(7)Å c=25.100(2)Å
α=90.00° β=90.00° γ=90.00°
C22H18N2O4
C22H18N2O4
RSC Adv. (2015)
a=14.6159(5)Å b=9.9444(3)Å c=28.7738(12)Å
α=90.00° β=90.00° γ=90.00°
C21H35N2O7PS2
C21H35N2O7PS2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 5 1451-1453
a=7.7391(3)Å b=9.1558(11)Å c=20.7496(17)Å
α=83.459(8)° β=85.820(5)° γ=69.189(7)°
C42H68N4NiO14P2S4,2(H2O)
C42H68N4NiO14P2S4,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 5 1451-1453
a=23.4963(6)Å b=8.2208(3)Å c=29.2604(8)Å
α=90.00° β=90.00° γ=90.00°
C30H46Cl2N4O9P2Pd2S4
C30H46Cl2N4O9P2Pd2S4
Dalton transactions (Cambridge, England : 2003) (2012) 41, 15 4324-4327
a=8.6119(9)Å b=11.1471(14)Å c=13.3906(9)Å
α=106.140(9)° β=99.678(7)° γ=108.160(10)°
C30H44N4O8P2PdS4,C4H8O2
C30H44N4O8P2PdS4,C4H8O2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 15 4324-4327
a=9.3910(5)Å b=9.6617(10)Å c=13.2526(14)Å
α=111.262(10)° β=104.326(7)° γ=92.377(7)°
C52H52Cl4N8Ni3O10P2S4,2(H2O)
C52H52Cl4N8Ni3O10P2S4,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2013) 42, 47 16470-16473
a=33.988(9)Å b=10.7792(10)Å c=23.245(6)Å
α=90.00° β=130.83(4)° γ=90.00°
C52H52Br4N8Ni3O10P2S4
C52H52Br4N8Ni3O10P2S4
Dalton transactions (Cambridge, England : 2003) (2013) 42, 47 16470-16473
a=33.853(19)Å b=10.6228(11)Å c=23.605(13)Å
α=90.00° β=130.11(9)° γ=90.00°
C24H38N6NiO4P2S4,CH2Cl2
C24H38N6NiO4P2S4,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2013) 42, 15 5252-5257
a=11.5622(6)Å b=16.9673(8)Å c=20.7405(9)Å
α=85.690(4)° β=82.885(4)° γ=71.258(4)°
C16H36N2O4P2S2
C16H36N2O4P2S2
Dalton transactions (Cambridge, England : 2003) (2013) 42, 15 5532-5538
a=17.7793(5)Å b=7.9981(2)Å c=17.2729(6)Å
α=90.00° β=91.163(3)° γ=90.00°
C4H12N2,2(C2H3O2)
C4H12N2,2(C2H3O2)
Dalton transactions (Cambridge, England : 2003) (2013) 42, 15 5532-5538
a=5.7855(3)Å b=7.0039(11)Å c=7.4459(11)Å
α=117.795(16)° β=100.317(9)° γ=90.118(9)°
C12H21N4O2PS2
C12H21N4O2PS2
CrystEngComm (2014) 16, 30 7053
a=17.145(3)Å b=14.7090(18)Å c=7.0193(11)Å
α=90.00° β=93.319(15)° γ=90.00°
C19H25N4O3PS2,C7H6O2
C19H25N4O3PS2,C7H6O2
CrystEngComm (2014) 16, 30 7053
a=6.8774(5)Å b=14.6409(14)Å c=15.1569(12)Å
α=70.775(8)° β=89.447(6)° γ=83.841(7)°
C19H24ClN4O3PS2
C19H24ClN4O3PS2
CrystEngComm (2014) 16, 30 7053
a=8.5874(7)Å b=11.9114(14)Å c=12.8574(15)Å
α=98.428(10)° β=109.104(9)° γ=96.547(8)°
C19H23Cl2N4O3PS2
C19H23Cl2N4O3PS2
CrystEngComm (2014) 16, 30 7053
a=9.0052(8)Å b=11.7572(10)Å c=12.3225(11)Å
α=98.558(7)° β=106.445(7)° γ=97.060(7)°
C19H24BrN4O3PS2
C19H24BrN4O3PS2
CrystEngComm (2014) 16, 30 7053
a=8.5957(13)Å b=11.821(2)Å c=12.807(2)Å
α=98.558(15)° β=108.643(15)° γ=97.790(15)°
(C19H23Br2N4O3PS2),CH3O0.5
(C19H23Br2N4O3PS2),CH3O0.5
CrystEngComm (2014) 16, 30 7053
a=25.4932(13)Å b=8.2482(5)Å c=25.1957(14)Å
α=90.00° β=101.280(4)° γ=90.00°
C12H21N4O2PS2
C12H21N4O2PS2
CrystEngComm (2014) 16, 30 7053
a=17.125(3)Å b=14.6887(18)Å c=7.0147(11)Å
α=90° β=93.338(16)° γ=90°
C19H23Cl2N4O3PS2
C19H23Cl2N4O3PS2
CrystEngComm (2014) 16, 30 7053
a=9.0052(8)Å b=11.7572(10)Å c=12.3225(11)Å
α=98.558(7)° β=106.445(7)° γ=97.060(7)°
C19H24ClN4O3PS2
C19H24ClN4O3PS2
CrystEngComm (2014) 16, 30 7053
a=8.5874(7)Å b=11.9114(14)Å c=12.8574(15)Å
α=98.428(10)° β=109.104(9)° γ=96.547(8)°
C19H24BrN4O3PS2
C19H24BrN4O3PS2
CrystEngComm (2014) 16, 30 7053
a=8.5957(13)Å b=11.821(2)Å c=12.807(2)Å
α=98.558(15)° β=108.643(15)° γ=97.790(15)°
(C19H23Br2N4O3PS2),CH3O0.5
(C19H23Br2N4O3PS2),CH3O0.5
CrystEngComm (2014) 16, 30 7053
a=25.4932(13)Å b=8.2482(5)Å c=25.1957(14)Å
α=90.00° β=101.280(4)° γ=90.00°
C18H20N2O4,0.5(C4H8O2)
C18H20N2O4,0.5(C4H8O2)
CrystEngComm (2014)
a=7.4692(8)Å b=22.575(2)Å c=22.4145(14)Å
α=90.00° β=91.242(6)° γ=90.00°
C18H18CuN2O4,2(H2O)
C18H18CuN2O4,2(H2O)
CrystEngComm (2014)
a=8.0257(3)Å b=19.2831(6)Å c=23.3907(7)Å
α=90.00° β=90.00° γ=90.00°
C18H18CuN2O4,CHCl3
C18H18CuN2O4,CHCl3
CrystEngComm (2014)
a=27.317(3)Å b=22.2583(14)Å c=6.9575(5)Å
α=90.00° β=90.00° γ=90.00°
S-naproxen L-alanine
C14H14O3,C3H7NO2
CrystEngComm (2014) 16, 35 8185
a=5.05836(11)Å b=7.1121(3)Å c=45.2723(17)Å
α=90° β=90° γ=90°
S-naproxen D-alanine
C14H14O3,C3H7NO2
CrystEngComm (2014) 16, 35 8185
a=5.3366(4)Å b=6.9013(6)Å c=44.227(4)Å
α=90° β=90° γ=90°
S-naproxen D-tyrosine
C14H14O3,C9H11NO3
CrystEngComm (2014) 16, 35 8185
a=9.4508(4)Å b=5.9725(2)Å c=18.9525(7)Å
α=90.00000° β=103.814(2)° γ=90.00000°
C22H26CuN2O8
C22H26CuN2O8
CrystEngComm (2014)
a=6.74840(10)Å b=21.9827(3)Å c=16.0526(2)Å
α=90° β=105.1720(10)° γ=90°
C18H18CuN2O4
C18H18CuN2O4
CrystEngComm (2014)
a=11.2596(2)Å b=23.9363(4)Å c=6.9871(2)Å
α=90.00° β=103.591(2)° γ=90.00°
C18H18N2NiO4,CH4O
C18H18N2NiO4,CH4O
CrystEngComm (2014)
a=11.1128(5)Å b=23.9480(10)Å c=7.1300(3)Å
α=90.00° β=103.599(5)° γ=90.00°
C15H20NO4P
C15H20NO4P
CrystEngComm (2013) 15, 39 7845
a=14.327(2)Å b=17.039(3)Å c=6.4900(11)Å
α=90.00° β=90.00° γ=90.00°
C32H36N4NiO6P2S2
C32H36N4NiO6P2S2
CrystEngComm (2013) 15, 39 7845
a=12.060(2)Å b=10.7171(10)Å c=13.9639(13)Å
α=90.00° β=90.435(11)° γ=90.00°
C16H19N2O3PS
C16H19N2O3PS
CrystEngComm (2013) 15, 39 7845
a=9.8501(12)Å b=11.0661(18)Å c=17.707(2)Å
α=92.032(11)° β=92.940(10)° γ=111.728(13)°
S-naproxen L-alanine
C14H14O3,C3H7NO2
CrystEngComm (2014) 16, 35 8185
a=5.05836(11)Å b=7.1121(3)Å c=45.2723(17)Å
α=90° β=90° γ=90°
S-naproxen D-alanine
C14H14O3,C3H7NO2
CrystEngComm (2014) 16, 35 8185
a=5.3366(4)Å b=6.9013(6)Å c=44.227(4)Å
α=90° β=90° γ=90°
S-naproxen D-tryptophan monohydrate
C14H14O3,C11H12N2O2,H2O
CrystEngComm (2014) 16, 35 8185
a=5.88418(16)Å b=11.3844(3)Å c=34.6863(9)Å
α=90° β=90° γ=90°
S-naproxen D-tyrosine
C14H14O3,C9H11NO3
CrystEngComm (2014) 16, 35 8185
a=9.4508(4)Å b=5.9725(2)Å c=18.9525(7)Å
α=90.00000° β=103.814(2)° γ=90.00000°
C8H10N4O2,C4H6O5
C8H10N4O2,C4H6O5
CrystEngComm (2014) 16, 41 9603
a=9.1390(11)Å b=9.3060(10)Å c=9.7714(12)Å
α=85.131(10)° β=65.297(13)° γ=71.185(11)°
2(C8H10N4O2),C6H10O4
2(C8H10N4O2),C6H10O4
CrystEngComm (2014) 16, 41 9603
a=21.3368(9)Å b=17.0520(5)Å c=6.7877(3)Å
α=90° β=93.674(4)° γ=90°
2(C8H10N4O2),C5H6O4
2(C8H10N4O2),C5H6O4
CrystEngComm (2014) 16, 41 9603
a=8.5926(3)Å b=18.4382(7)Å c=14.9164(5)Å
α=90° β=92.437(3)° γ=90°
2(C8H10N4O2),C5H6O4
2(C8H10N4O2),C5H6O4
CrystEngComm (2014) 16, 41 9603
a=7.9317(6)Å b=8.2797(2)Å c=20.4795(15)Å
α=89.975(6)° β=83.335(6)° γ=61.808(6)°
4(C8H10N4O2),2(C5H6O4),C2H3N
4(C8H10N4O2),2(C5H6O4),C2H3N
CrystEngComm (2014) 16, 41 9603
a=44.164(3)Å b=3.94516(19)Å c=27.676(3)Å
α=90° β=96.236(8)° γ=90°
C34H39N4O2,0.5(Cl18Hg6),2(H2O)
C34H39N4O2,0.5(Cl18Hg6),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 29 13186-13195
a=10.4157(7)Å b=11.8752(10)Å c=19.1618(12)Å
α=102.897(6)° β=96.838(5)° γ=97.923(6)°
5-phenyl-2-(2-pyridyl)pyridine
2(C8H6N),C8H6N1
Dalton transactions (Cambridge, England : 2003) (2015) 44, 38 16824-16832
a=5.6180(10)Å b=15.682(3)Å c=19.716(3)Å
α=90° β=91.990(2)° γ=90°
C52H42CuN2P2,BF4
C52H42CuN2P2,BF4
Dalton transactions (Cambridge, England : 2003) (2015) 44, 38 16824-16832
a=10.5921(4)Å b=13.9695(6)Å c=15.0293(5)Å
α=90° β=94.299(3)° γ=90°
C34H27CuIN2P
C34H27CuIN2P
Dalton transactions (Cambridge, England : 2003) (2015) 44, 38 16824-16832
a=9.3666(3)Å b=10.2614(3)Å c=30.1047(11)Å
α=90° β=93.907(3)° γ=90°
C15H11IN4
C15H11IN4
Acta Crystallographica Section B (2018) 74, 6
a=15.0197(4)Å b=15.0197(4)Å c=12.8791(6)Å
α=90° β=90° γ=90°
C13H10IN3O
C13H10IN3O
Acta Crystallographica Section B (2018) 74, 6
a=10.0223(9)Å b=11.1984(3)Å c=12.4505(10)Å
α=109.836(6)° β=101.250(7)° γ=97.494(6)°
C15H12N4O,CH2Cl2
C15H12N4O,CH2Cl2
Acta Crystallographica Section B (2018) 74, 6
a=9.51859(16)Å b=15.70955(19)Å c=21.6869(3)Å
α=90° β=98.0651(15)° γ=90°
C15H11BrN4
C15H11BrN4
Acta Crystallographica Section B (2018) 74, 6
a=14.8761(7)Å b=4.0269(2)Å c=23.1830(12)Å
α=90° β=105.810(5)° γ=90°
2'-(4-Hydroxybenzylidene)isonicotinohydrazide monohydrate
C13H11N3O2,H2O
Acta Crystallographica Section B (2018) 74, 6
a=7.0488(15)Å b=12.150(3)Å c=28.649(6)Å
α=90.00° β=90.00° γ=90.00°
N'-(4-Hydroxybenzylidene)isonicotinohydrazide
C13H11N3O2
Acta Crystallographica Section B (2018) 74, 6
a=8.4553(14)Å b=10.1812(16)Å c=13.408(2)Å
α=90.00° β=98.646(2)° γ=90.00°
C13H10BrN3O
C13H10BrN3O
Acta Crystallographica Section B (2018) 74, 6
a=18.763(3)Å b=6.5126(7)Å c=10.1237(15)Å
α=90° β=95.458(15)° γ=90°
Pentakis(μ-carbonyl-κ^2^<i>C</i>:<i>C</i>)tetrakis(triphenylphosphane-κ<i>P</i>)tetrapalladium(5 <i>Pd</i>—–-<i>Pd</i>) tetrahydrofuran disolvate
C77H60O5P4Pd4,2(C4H8O)
Acta Crystallographica Section E (2016) 72, 2 120-123
a=27.254(9)Å b=16.016(6)Å c=17.938(7)Å
α=90° β=105.92(2)° γ=90°
Trans-Chlorido[6-chloro-4-(4-methoxybenzyl)-3-oxo-3,4-dihydropyrazin-2- yl]bis(triphenylphosphine)palladium(II)
C48H40Cl2N2O2P2Pd
Acta Crystallographica Section E (2008) 64, 1 m93-m93
a=10.75440(10)Å b=13.15260(10)Å c=16.99670(10)Å
α=91.8110(10)° β=94.390(10)° γ=98.4510(10)°
Ethyl 2-(2,3-dioxoindolin-1-yl)acetate
C12H11NO4
Acta Crystallographica Section E (2007) 63, 4 o1747-o1748
a=13.6433(6)Å b=4.9505(3)Å c=16.2899(8)Å
α=90.00° β=104.246(2)° γ=90.00°
Hexakis(adamantyltrimethylammonium) cyclooctasilicate tetratetracontahydrate
6(C13H24N),H2O20Si86,44(H2O)
Acta Crystallographica Section C (2010) 66, 12 o619-o622
a=15.5889(8)Å b=15.9297(8)Å c=16.2269(11)Å
α=60.863(2)° β=72.511(3)° γ=82.119(2)°
AlB4H18N
AlB4H18N
Chemistry of Materials (2015) 27, 3 768
a=10.8196(8)Å b=7.2809(4)Å c=11.3260(9)Å
α=90° β=107.695(8)° γ=90°
AlB4H18N
AlB4H18N
Chemistry of Materials (2015) 27, 3 768
a=7.8585(2)Å b=6.86473(14)Å c=15.7136(8)Å
α=90° β=96.429(4)° γ=90°
C57H36Co3N15O7,ClO4
C57H36Co3N15O7,ClO4
ACS applied materials & interfaces (2019) 11, 3 3181-3188
a=16.6138(8)Å b=16.6138(8)Å c=24.2258(12)Å
α=90° β=90° γ=120°
C57H36Co3N15O7
C57H36Co3N15O7
ACS applied materials & interfaces (2019) 11, 3 3181-3188
a=16.6264(7)Å b=16.6264(7)Å c=24.2500(13)Å
α=90° β=90° γ=120°
C63H42Co3N16O10
C63H42Co3N16O10
ACS applied materials & interfaces (2019) 11, 3 3181-3188
a=16.6267(3)Å b=16.6267(3)Å c=28.9795(7)Å
α=90° β=90° γ=120°
C63H42Co3N15O7,BF4
C63H42Co3N15O7,BF4
ACS applied materials & interfaces (2019) 11, 3 3181-3188
a=16.7599(5)Å b=16.7599(5)Å c=29.0651(9)Å
α=90° β=90° γ=120°
C45H30Co3N15O7,(CNS)[solvent]
C45H30Co3N15O7,(CNS)[solvent]
ACS applied materials & interfaces (2019) 11, 3 3181-3188
a=16.8384(10)Å b=16.8384(10)Å c=19.0516(13)Å
α=90° β=90° γ=120°
C45H30Co3N15O7,NO3
C45H30Co3N15O7,NO3
ACS applied materials & interfaces (2019) 11, 3 3181-3188
a=16.7567(5)Å b=16.7567(5)Å c=19.0343(7)Å
α=90° β=90° γ=120°
C45H30Co3N15O7,Br
C45H30Co3N15O7,Br
ACS applied materials & interfaces (2019) 11, 3 3181-3188
a=16.6968(9)Å b=16.6968(9)Å c=18.9684(10)Å
α=90° β=90° γ=120°
C8H14N2O2,C6H10O4
C8H14N2O2,C6H10O4
Crystal Growth & Design (2014) 14, 6 2880
a=12.9082(9)Å b=11.5417(8)Å c=12.5179(9)Å
α=90.00° β=116.342(9)° γ=90.00°
Levetiracetam 2,2-dimethylsuccinic acid cocrystal
C8H14N2O2,C6H10O4
Crystal Growth & Design (2014) 14, 6 2880
a=6.23877(7)Å b=11.55362(12)Å c=11.34360(12)Å
α=90.00000° β=90.9259(9)° γ=90.00000°
C8H14N2O2,C7H6O4
C8H14N2O2,C7H6O4
Crystal Growth & Design (2014) 14, 6 2880
a=6.2828(3)Å b=13.3843(6)Å c=18.7984(8)Å
α=90.00° β=96.638(4)° γ=90.00°
Etiracetam 2,4-dihydroxybenzoic acid cocrystal
C8H14N2O2,C7H6O4
Crystal Growth & Design (2014) 14, 6 2880
a=6.60584(3)Å b=13.11919(7)Å c=18.80723(8)Å
α=90.00000° β=90.00000° γ=90.00000°
C8H14N2O2,C7H5NO4
C8H14N2O2,C7H5NO4
Crystal Growth & Design (2014) 14, 6 2880
a=5.8455(2)Å b=11.6845(12)Å c=12.5762(10)Å
α=78.856(8)° β=82.443(6)° γ=84.035(7)°
C8H14N2O2,2(C7H5NO4)
C8H14N2O2,2(C7H5NO4)
Crystal Growth & Design (2014) 14, 6 2880
a=8.0511(4)Å b=13.0536(6)Å c=23.0243(9)Å
α=90.00° β=90.00° γ=90.00°
C8H14N2O2,2(C7H5NO4)
C8H14N2O2,2(C7H5NO4)
Crystal Growth & Design (2014) 14, 6 2880
a=24.2697(8)Å b=7.4683(2)Å c=13.3230(5)Å
α=90.00° β=104.663(4)° γ=90.00°
2(C7H5NO4),C8H14N2O2
2(C7H5NO4),C8H14N2O2
Crystal Growth & Design (2014) 14, 6 2880
a=7.0988(9)Å b=7.3613(10)Å c=12.1428(13)Å
α=77.496(10)° β=88.250(10)° γ=74.232(12)°
C8H14N2O2,C2H2O4
C8H14N2O2,C2H2O4
Crystal Growth & Design (2014) 14, 6 2880
a=5.7253(2)Å b=20.2528(7)Å c=10.9457(5)Å
α=90.00° β=100.085(4)° γ=90.00°